Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.48 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | ABHD16A | O95870 | 1/20 | 0.44 |
| ▸ | PRKCA | P17252 | 4/20 | 0.44 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | FASN | P49327 | 1/20 | 0.41 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.41 |
| ▸ | PRKCG | P05129 | 1/20 | 0.41 |
| ▸ | PRKCB | P05771 | 1/20 | 0.41 |
| ▸ | PRKCH | P24723 | 1/20 | 0.41 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.41 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.41 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.41 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3923431 | 1.00 | CYP1A2 (0.48) | CYP1A2CES2ABHD16APRKCADAGLA | |
| SCHEMBL3792733 | 1.00 | CYP1A2 (0.48) | CYP1A2CES2ABHD16APRKCADAGLA | |
| SCHEMBL3792236 | 1.00 | CYP1A2 (0.48) | CYP1A2CES2ABHD16APRKCADAGLA | |
| SCHEMBL15660716 | 0.98 | CYP1A2 (0.50) | CYP1A2CES2ABHD16APRKCADAGLA | |
| SCHEMBL6580106 | 0.98 | CYP1A2 (0.50) | CYP1A2CES2ABHD16APRKCADAGLA | |
| SCHEMBL5694481 | 0.98 | CYP1A2 (0.46) | CYP1A2CES2ABHD16APRKCADAGLA | |
| SCHEMBL15658403 | 0.98 | CYP1A2 (0.50) | CYP1A2CES2ABHD16APRKCADAGLA | |
| SCHEMBL15659839 | 0.98 | CYP1A2 (0.50) | CYP1A2CES2ABHD16APRKCADAGLA | |
| SCHEMBL14718758 | 0.98 | CYP1A2 (0.50) | CYP1A2CES2ABHD16APRKCADAGLA | |
| SCHEMBL15655302 | 0.98 | CYP1A2 (0.50) | CYP1A2CES2ABHD16APRKCADAGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1883665-B1 | POLYLACTIDE COMPOSITIONS AND USES THEREOF | UNIV GENEVE (CH) | 2017-10-11 | — | — | EP | claimed |
| US-20090281068-A1 | POLYLACTIDE COMPOSITIONS AND USES THEREOF | UNIVERSITY OF GENEVA | 2009-11-12 | — | — | US | claimed |
| EP-1883665-A2 | POLYLACTIDE COMPOSITIONS AND USES THEREOF | UNIVERSITE DE GENEVE (CH) | 2008-02-06 | — | — | EP | claimed |
| WO-2007012979-A2 | POLYLACTIDE COMPOSITIONS AND USES THEREOF | UNIVERSITE DE GENEVE (US) | 2007-02-01 | — | — | WO | claimed |
| US-10314913-B2 | Polylactide compositions and uses thereof | UNIVERSITY OF GENEVA (CH) | 2019-06-11 | — | — | US | disclosed |
| US-10314913-B2 | Polylactide compositions and uses thereof | UNIVERSITY OF GENEVA (CH) | 2019-06-11 | — | — | US | disclosed |
| US-20180271984-A1 | POLYLACTIDE COMPOSITIONS AND USES THEREOF | UNIVERSITY OF GENEVA (CH) | 2018-09-27 | — | — | US | disclosed |
| EP-3339348-A1 | POLYLACTIDE COMPOSITIONS AND USES THEREOF | Universite De Geneve (CH) | 2018-06-27 | — | — | EP | disclosed |
| EP-3339348-A1 | POLYLACTIDE COMPOSITIONS AND USES THEREOF | Universite De Geneve (CH) | 2018-06-27 | — | — | EP | disclosed |
| US-9925267-B2 | Polylactide compositions and uses thereof | UNIVERSITY OF GENEVA (CH) | 2018-03-27 | — | — | US | disclosed |
| US-9925267-B2 | Polylactide compositions and uses thereof | UNIVERSITY OF GENEVA (CH) | 2018-03-27 | — | — | US | disclosed |
| US-9925267-B2 | Polylactide compositions and uses thereof | UNIVERSITY OF GENEVA (CH) | 2018-03-27 | — | — | US | disclosed |
| US-20090281068-A1 | POLYLACTIDE COMPOSITIONS AND USES THEREOF | UNIVERSITY OF GENEVA | 2009-11-12 | — | — | US | disclosed |
| US-7589156-B2 | Polyhydroxyalkanoic acid having ester, carboxyl or sulfonic acid group, and producing method therefor | CANON KABUSHIKI KAISHA (JP) | 2009-09-15 | — | — | US | disclosed |
| EP-1883665-A2 | POLYLACTIDE COMPOSITIONS AND USES THEREOF | UNIVERSITE DE GENEVE (CH) | 2008-02-06 | — | — | EP | disclosed |
| US-20070117937-A1 | Polyhydroxyalkanoic acid having ester, carboxyl or sulfonic acid group and producing method thereor | CANON KABUSHIKI KAISHA (JP) | 2007-05-24 | — | — | US | disclosed |
| WO-2007012979-A2 | POLYLACTIDE COMPOSITIONS AND USES THEREOF | UNIVERSITE DE GENEVE (US) | 2007-02-01 | — | — | WO | disclosed |
| WO-2007012979-A2 | POLYLACTIDE COMPOSITIONS AND USES THEREOF | UNIVERSITE DE GENEVE (US) | 2007-02-01 | — | — | WO | disclosed |
| EP-0586575-A1 | DEGRADABLE CELLULOSE POLYMERS | BATTELLE MEMORIAL INSTITUTE (US) | 1994-03-16 | — | — | EP | disclosed |
| WO-1992020738-A1 | DEGRADABLE CELLULOSE POLYMERS | BATTELLE MEMORIAL INSTITUTE (US) | 1992-11-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10314913-B2 | Polylactide compositions and uses thereof | LPXN, PUF60, DDOST | CYP1A2 1591/4885CES2 146/4885ABHD16A 58/4885 |
| US-20090281068-A1 | POLYLACTIDE COMPOSITIONS AND USES THEREOF | LPXN, PUF60, DDOST | CYP1A2 1591/4885CES2 146/4885ABHD16A 58/4885 |
| US-20180271984-A1 | POLYLACTIDE COMPOSITIONS AND USES THEREOF | LPXN, PUF60, DDOST | CYP1A2 1591/4885CES2 146/4885ABHD16A 58/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.